1085P Adoptive cell therapy with TCR gene-engineered T cells directed against MAGE-C2-positive melanoma: An ongoing phase I trial

Autor: van Dijk, B. 1, Lamers, C. 1, de Joode, K. 1, de Beijer, M. 1, Berrevoets, C. 1, van Brakel, M. 1, Tsui, J. 2, Bezemer, K. 2, de Wilde, S. 2, de Jonge, M.J.A. 1, Sleijfer, S. 1, Van der Veldt, A.A.M. 3, Debets, R. 1
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S719-S719
Databáze: ScienceDirect